Can Mesenchymal Stem Cells Act Multipotential in Traumatic Brain Injury?

Area of Science:

• Neuroscience
• Regenerative Medicine
• Traumatology

Background:

• Traumatic brain injury (TBI) is a significant global health issue with limited effective treatments.
• TBI's heterogeneous nature necessitates multipotential therapeutic strategies targeting multiple mechanisms.
• Mesenchymal stem cells (MSCs) are emerging as a promising therapeutic avenue for brain injury repair.

Purpose of the Study:

• To explore the potential of mesenchymal stem cells (MSCs) as a therapeutic strategy for traumatic brain injury (TBI).
• To summarize the observed effects of MSCs transplantation in preclinical models of TBI.

Main Methods:

• Review of preclinical studies investigating MSCs transplantation in TBI models.
• Analysis of MSCs' migratory capacity, differentiation potential, and therapeutic effects.

Main Results:

• MSCs demonstrated migration to TBI sites and secretion of beneficial factors.
• Observed benefits include reduced brain edema, neuroinflammation, apoptosis, and ischemia.
• Improvements in motor/cognitive function, neurogenesis, and angiogenesis were noted.

Conclusions:

• MSCs transplantation offers a promising multipotential therapeutic approach for TBI.
• Observed preclinical benefits suggest MSCs could address TBI's complexity.
• Additional preclinical research is crucial for advancing MSCs therapy for TBI into clinical practice.